Novartis Builds on Radiopharmaceuticals Platform with Endocyte Acquisition
By Michelle Liu
Pharma Deals Review: Vol 2018 Issue 10 (Table of Contents)
Published: 27 Oct-2018
DOI: 10.3833/pdr.v2018.i10.2365 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Further expanding its reach in the oncology market, Novartis has struck a deal to acquire US company, Endocyte, which uses drug conjugation technology to target therapeutics and companion imaging agents for the treatment of cancer for US$2...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS